252 related articles for article (PubMed ID: 31145798)
1. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
Schunkert H; Boening A; von Scheidt M; Lanig C; Gusmini F; de Waha A; Kuna C; Fach A; Grothusen C; Oberhoffer M; Knosalla C; Walther T; Danner BC; Misfeld M; Zeymer U; Wimmer-Greinecker G; Siepe M; Grubitzsch H; Joost A; Schaefer A; Conradi L; Cremer J; Hamm C; Lange R; Radke PW; Schulz R; Laufer G; Grieshaber P; Pader P; Attmann T; Schmoeckel M; Meyer A; Ziegelhöffer T; Hambrecht R; Kastrati A; Sandner SE
Eur Heart J; 2019 Aug; 40(29):2432-2440. PubMed ID: 31145798
[TBL] [Abstract][Full Text] [Related]
2. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor or Aspirin After Coronary Artery Bypass in Patients With Chronic Kidney Disease.
Sandner SE; Schunkert H; Kastrati A; Milojevic M; Böning A; Zimpfer D; Zellmer S; Wiedemann D; Laufer G; von Scheidt M;
Ann Thorac Surg; 2022 Feb; 113(2):554-562. PubMed ID: 33819474
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor monotherapy versus aspirin in patients undergoing multiple arterial or single arterial coronary artery bypass grafting: insights from the TiCAB trial.
Sandner SE; Schunkert H; Kastrati A; Wiedemann D; Misfeld M; Böning A; Tebbe U; Nowak B; Stritzke J; Laufer G; von Scheidt M;
Eur J Cardiothorac Surg; 2020 Apr; 57(4):732-739. PubMed ID: 31750899
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.
Sardella G; Beerkens FJ; Dangas G; Cao D; Baber U; Sartori S; Cohen DJ; Briguori C; Gil R; Nicolas J; Zhang Z; Dudek D; Kunadian V; Kornowski R; Weisz G; Claessen B; Marx S; Escaned J; Huber K; Collier T; Moliterno DJ; Ohman EM; Krucoff MW; Kastrati A; Steg PG; Angiolillo DJ; Mehta S; Shlofmitz R; Sharma S; Pocock S; Gibson CM; Mehran R
EuroIntervention; 2022 Dec; 18(11):e897-e909. PubMed ID: 35979636
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
Zhu Y; Zhang W; Dimagli A; Han L; Cheng Z; Mei J; Chen X; Wang X; Zhou Y; Xue Q; Hu J; Tang M; Wang R; Song Y; Kang L; Redfors B; Gaudino M; Zhao Q
BMJ; 2024 Jun; 385():e075707. PubMed ID: 38862179
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.
Vogel B; Baber U; Cohen DJ; Sartori S; Sharma SK; Angiolillo DJ; Farhan S; Goel R; Zhang Z; Briguori C; Collier T; Dangas G; Dudek D; Escaned J; Gil R; Han YL; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Mehta SR; Moliterno D; Ohman EM; Sardella G; Witzenbichler B; Gibson CM; Pocock S; Huber K; Mehran R
JAMA Cardiol; 2021 Sep; 6(9):1032-1041. PubMed ID: 33991416
[TBL] [Abstract][Full Text] [Related]
10. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome.
Björklund E; Malm CJ; Nielsen SJ; Hansson EC; Tygesen H; Romlin BS; Martinsson A; Omerovic E; Pivodic A; Jeppsson A
JAMA Netw Open; 2021 Aug; 4(8):e2122597. PubMed ID: 34436610
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
[TBL] [Abstract][Full Text] [Related]
13. Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting.
Gherli R; Mariscalco G; Dalén M; Onorati F; Perrotti A; Chocron S; Verhoye JP; Gulbins H; Reichart D; Svenarud P; Faggian G; Santarpino G; Fischlein T; Maselli D; Dominici C; Musumeci F; Rubino AS; Mignosa C; De Feo M; Bancone C; Gatti G; Maschietto L; Santini F; Nicolini F; Gherli T; Zanobini M; Kinnunen EM; Ruggieri VG; Rosato S; Biancari F
JAMA Cardiol; 2016 Nov; 1(8):921-928. PubMed ID: 27653165
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
Mehran R; Baber U; Sharma SK; Cohen DJ; Angiolillo DJ; Briguori C; Cha JY; Collier T; Dangas G; Dudek D; Džavík V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta SR; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM
N Engl J Med; 2019 Nov; 381(21):2032-2042. PubMed ID: 31556978
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
[TBL] [Abstract][Full Text] [Related]
17. Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trial.
Sandner S; Kastrati A; Niessner A; Böning A; Zeymer U; Conradi L; Danner B; Zimpfer D; Färber G; Manville E; Schunkert H; von Scheidt M;
Int J Cardiol; 2023 Jan; 370():129-135. PubMed ID: 36328115
[TBL] [Abstract][Full Text] [Related]
18. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effects of ticagrelor versus clopidogrel after coronary artery bypass graft surgery: A single-center randomized controlled trial.
Xu F; Feng W; Zhou Z; Zhang Y; Diao X; Hu S; Zheng Z
J Thorac Cardiovasc Surg; 2019 Aug; 158(2):430-437.e4. PubMed ID: 30501950
[TBL] [Abstract][Full Text] [Related]
20. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
